MX2012005165A - Proceso para la preparacion de inhibidor de pirazinona trombina y sus intermediarios. - Google Patents
Proceso para la preparacion de inhibidor de pirazinona trombina y sus intermediarios.Info
- Publication number
- MX2012005165A MX2012005165A MX2012005165A MX2012005165A MX2012005165A MX 2012005165 A MX2012005165 A MX 2012005165A MX 2012005165 A MX2012005165 A MX 2012005165A MX 2012005165 A MX2012005165 A MX 2012005165A MX 2012005165 A MX2012005165 A MX 2012005165A
- Authority
- MX
- Mexico
- Prior art keywords
- intermediates
- preparation
- thrombin inhibitor
- pyrazinone
- pyrazinone thrombin
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- HUTNOYOBQPAKIA-UHFFFAOYSA-N 1h-pyrazin-2-one Chemical compound OC1=CN=CC=N1 HUTNOYOBQPAKIA-UHFFFAOYSA-N 0.000 title 1
- 101000712605 Theromyzon tessulatum Theromin Proteins 0.000 title 1
- 229940122388 Thrombin inhibitor Drugs 0.000 title 1
- 239000003868 thrombin inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2663CH2009 | 2009-11-03 | ||
| PCT/US2010/055176 WO2011056806A1 (en) | 2009-11-03 | 2010-11-02 | Process for the preparation of pyrazinone thrombin inhibitor and its intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012005165A true MX2012005165A (es) | 2012-08-08 |
Family
ID=43926105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012005165A MX2012005165A (es) | 2009-11-03 | 2010-11-02 | Proceso para la preparacion de inhibidor de pirazinona trombina y sus intermediarios. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8541580B2 (enExample) |
| EP (1) | EP2496087A4 (enExample) |
| JP (1) | JP2013510159A (enExample) |
| KR (1) | KR20120106727A (enExample) |
| CN (1) | CN102711481A (enExample) |
| AU (1) | AU2010315338A1 (enExample) |
| CA (1) | CA2778922A1 (enExample) |
| MX (1) | MX2012005165A (enExample) |
| RU (1) | RU2012118499A (enExample) |
| WO (1) | WO2011056806A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10016417B2 (en) | 2011-11-07 | 2018-07-10 | Diakron Pharmaceuticals, Inc. | Extended release formulation of a direct thrombin inhibitor |
| CN108430986B (zh) | 2015-10-26 | 2021-08-31 | 拜耳作物科学股份公司 | 作为有害生物控制剂的稠合双环杂环衍生物 |
| PH12021552065A1 (en) | 2019-02-26 | 2022-05-23 | Bayer Ag | Condensed bicyclic heterocyclic derivatives as pest control agents |
| CN113710669A (zh) | 2019-02-26 | 2021-11-26 | 拜耳公司 | 作为农药的稠合双环杂环衍生物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6147078A (en) * | 1998-05-19 | 2000-11-14 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| UA58636C2 (uk) * | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням |
| AU2002232533A1 (en) * | 2000-12-06 | 2002-06-18 | Merck & Co., Inc. | Process for making a thrombin inhibitor |
| EP1422221A1 (en) | 2002-11-20 | 2004-05-26 | Bayer CropScience SA | Novel process for the preparation of 2-aminomethylpyridine derivative |
-
2010
- 2010-11-02 MX MX2012005165A patent/MX2012005165A/es active IP Right Grant
- 2010-11-02 EP EP10828989.3A patent/EP2496087A4/en not_active Withdrawn
- 2010-11-02 KR KR1020127010789A patent/KR20120106727A/ko not_active Ceased
- 2010-11-02 US US12/938,297 patent/US8541580B2/en not_active Expired - Fee Related
- 2010-11-02 CN CN2010800499062A patent/CN102711481A/zh active Pending
- 2010-11-02 AU AU2010315338A patent/AU2010315338A1/en not_active Abandoned
- 2010-11-02 RU RU2012118499/04A patent/RU2012118499A/ru not_active Application Discontinuation
- 2010-11-02 WO PCT/US2010/055176 patent/WO2011056806A1/en not_active Ceased
- 2010-11-02 CA CA2778922A patent/CA2778922A1/en not_active Abandoned
- 2010-11-02 JP JP2012537955A patent/JP2013510159A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120106727A (ko) | 2012-09-26 |
| US8541580B2 (en) | 2013-09-24 |
| EP2496087A1 (en) | 2012-09-12 |
| US20110105753A1 (en) | 2011-05-05 |
| AU2010315338A1 (en) | 2012-05-24 |
| CA2778922A1 (en) | 2011-05-12 |
| WO2011056806A1 (en) | 2011-05-12 |
| CN102711481A (zh) | 2012-10-03 |
| EP2496087A4 (en) | 2013-06-19 |
| JP2013510159A (ja) | 2013-03-21 |
| RU2012118499A (ru) | 2013-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2011000673A1 (en) | Bace inhibitors | |
| SG179085A1 (en) | Pi3 kinase inhibitors and uses thereof | |
| WO2011072099A3 (en) | Compositions and methods comprising protease variants | |
| MX345909B (es) | Anticuerpos anti-fgfr3 y métodos que los utilizan. | |
| IN2009DN05670A (enExample) | ||
| WO2011002808A8 (en) | Hcv protease inhibitors and uses thereof | |
| EP3608021A3 (en) | Analyte detection devices, multiplex and tabletop devices for detection of analytes, and uses thereof | |
| PH12012501346A1 (en) | Heteroaryl compounds and uses thereof | |
| PH12013502230A1 (en) | Multispecific antibodies | |
| PH12013500500A1 (en) | Fused heteroaryls and their uses | |
| MY181898A (en) | Heterocyclic compounds and uses thereof | |
| PH12012500954A1 (en) | Method for producing dabigatran etexilate | |
| CR20130138A (es) | Proceso para la preparación de inhibidores de pan-cdk de la fórmula (i), e intermediarios de la preparación | |
| MY147732A (en) | Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines | |
| MX2011010012A (es) | NUEVOS ANTICUERPOS ANTI-A5ß1 Y SUS USOS. | |
| WO2011130222A3 (en) | Compositions and methods comprising variant proteases | |
| MX2011011272A (es) | Procesos e intermediarios. | |
| MX2013004143A (es) | Toallitas humadas, articulos de fabricacion y metodos para fabricarlas. | |
| MY161473A (en) | Compositions, synthesis, and methods of utilizing arylpiperazine derivatives | |
| WO2009150547A3 (en) | 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors | |
| MY155330A (en) | Methods for salt production | |
| JO2978B1 (en) | MGLU2 aids | |
| CA2843611C (en) | Compositions and methods for reducing the incidence of equine digestive disorders | |
| MX336742B (es) | Inhibidores de amida hidrolasa de acido graso. | |
| WO2008075205A3 (en) | Improved process for the preparation of voriconazole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |